The Early Lymphatic Spread of Manifest Prostatic Adenocarcinoma

Grossman, Ira; R, von Phul; Jp, Fitzgerald; Masih, Sulabha; Turner, Frank G.; Ss, Kurohara; George, F.W.

doi:10.2214/ajr.120.3.673

Cited by 17 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although lymphography has become a routine procedure in certain diseases such as lymphomas, its role in prostatic carcinoma is controversial [7,8]. Grossman and associates stated that lymphography is better than serum acid phosphatase determinations in assessing the extent of disease [9], but Paulson and others have revealed a high degree of error [ 1 1,121. In the present preliminary study, all four cases with positive lymphograms had already presented with skeletal involvement.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic procedures for assessment of disease extent in prostatic carcinoma

et al. 1981

View full text Add to dashboard Cite

Staging of carcinoma of the prostate was performed on patients using Watanabe's method of transrectal ultrasonotomography (N = 37), pedal lymphography (N = 10), and bone scanning with technetium phosphate (N = 35). Of 14 patients found to have tumor confined within the prostate following routine examination, 4 were elevated to a higher disease stage after sonographic evaluation. Thirty‐two percent of 25 patients with normal bone X‐rays had abnormal bone scans. Four cases with positive node metastases on lymphogram had already presented with skeletal involvment. The values of these techniques in the assessment of disease extent in prostatic carcinoma are compared and briefly discussed.

show abstract

Section: Discussionmentioning

confidence: 99%

Diagnostic procedures for assessment of disease extent in prostatic carcinoma

et al. 1981

View full text Add to dashboard Cite

show abstract

“…The majority of patients received 5500 rads in 4 weeks using a three-field technique. Grossman et al (36), reporting on 58 patients treated to doses of 7200 rads in 11 weeks and followed from 12-24 months, showed the apparent feasibility of treating extensive volumes without undue patient morbidity. The data of investigators using a variety of techniques and sources of radiation ( Table 4) tend to support our impression that potentially tumoricidal doses of irradiation can be delivered to the prostate with relative safety.…”

Section: External Beam Megavoltage Radiation Therapymentioning

confidence: 99%

The Role of Radiation Therapy in the Definitive Treatment of Adenocarcinoma of the Prostate

Ray¹,

Bagshaw²

1975

Annu. Rev. Med.

View full text Add to dashboard Cite

External beam radiation therapy of primary carcinoma of the prostate

Bagshaw¹,

Ray²,

Pistenma³

et al. 1975

Cancer

124

View full text Add to dashboard Cite

During the past 10 years, some 15 publications have appeared in the English literature on the definitive radiotherapy of prostatic cancer. The long-term followup required for rational assessment of the treatment of prostatic cancer is not yet available for most of these studies. However, in the Stanford series, the direct disease-free survival at 5 years for patients with disease localized to the prostate is 70%; at 10 years, 42%. The direct disease-free survival at 5 years for patients with extracapsular extension in 36%, and at 10 years, 29%. Recently, mapping of potential lymph node metastases has been studies by several authors.Early results of extended-field irradiation required for regional treatment are presented.

show abstract

The Early Lymphatic Spread of Manifest Prostatic Adenocarcinoma

Cited by 17 publications

References 0 publications

Diagnostic procedures for assessment of disease extent in prostatic carcinoma

Diagnostic procedures for assessment of disease extent in prostatic carcinoma

The Role of Radiation Therapy in the Definitive Treatment of Adenocarcinoma of the Prostate

External beam radiation therapy of primary carcinoma of the prostate

Contact Info

Product

Resources

About